AIMS: The study analysed post-acute COVID-19 symptoms and the pulmonary function test (PFT) results in patients surviving the native strain of the virus. METHODS: The study was prospective; the inclusion criteria were positive PCR test for SARS-CoV-2 and age 18-100. Exclusion criteria were active respiratory infection, known or suspicious pre-existing pulmonary disease, cardiac failure, recent or acute pulmonary embolism, anaemia, and neuromuscular diseases. The recruitment period was 1st March 2020 - 25th December 2020. The initial examination was performed 4-12 weeks after the disease onset. All subjects underwent physical examination, anamnesis, chest x-ray and PFT. RESULTS: The study involved 785 subjects (345 male) mean age 53.8 (SD 14.6). The disease severity groups were: mild (G1), moderate (G2) and severe/critical (G3). Anosmia was present in the acute disease phase in 45.2% of G1 patients, but only in 4.5% of G3 patients. Dyspnoea occurred frequently in more severe groups (40%, 51.8% and 63.7% for G1, G2 and G3 respectively), while cough and fatigue showed no relationship to disease severity. Females were more likely to experience persistent symptoms. PFT results were significantly decreased in more severe groups compared to the mild COVID-19 patients, diffusing capacity was 86.3%, 79% and 68% of predicted values in G1, G2 and G3 respectively. CONCLUSION: Anosmia during the acute phase was associated with mild disease, persisting dyspnoea was more frequent after more severe COVID-19. Females tended to have persisting symptoms in post-acute phase more frequently. PFT results showed decrease with disease severity.

Department of Respiratory Diseases and Tuberculosis University Hospital and Faculty of Medicine and Dentistry Pavol Jozef Safarik University Kosice Slovak Republic

Department of Respiratory Diseases and Tuberculosis University Hospital Brno and Faculty of Medicine and Dentistry Masaryk University Brno Czech Republic

Department of Respiratory Diseases and Tuberculosis University Hospital Olomouc and Faculty of Medicine and Dentistry Palacky University Olomouc Olomouc Czech Republic

Department of Telecommunications University of Technology Brno Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc23008946

003      

CZ-PrNML

005      

20230802075202.0

007      

ta

008      

230707s2023 xr d f 000 0|eng||

009      

AR

024    7_

$a 10.5507/bp.2022.039 $2 doi

035    __

$a (PubMed)36128850

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xr

100    1_

$a Genzor, Samuel $u Department of Respiratory Diseases and Tuberculosis, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic $7 xx0219019

245    10

$a Clinical presentation and pulmonary function tests in post-acute COVID-19 patients / $c S. Genzor, P. Jakubec, M. Sova, J. Mizera, P. Joppa, R. Burget, P. Pobeha

520    9_

$a AIMS: The study analysed post-acute COVID-19 symptoms and the pulmonary function test (PFT) results in patients surviving the native strain of the virus. METHODS: The study was prospective; the inclusion criteria were positive PCR test for SARS-CoV-2 and age 18-100. Exclusion criteria were active respiratory infection, known or suspicious pre-existing pulmonary disease, cardiac failure, recent or acute pulmonary embolism, anaemia, and neuromuscular diseases. The recruitment period was 1st March 2020 - 25th December 2020. The initial examination was performed 4-12 weeks after the disease onset. All subjects underwent physical examination, anamnesis, chest x-ray and PFT. RESULTS: The study involved 785 subjects (345 male) mean age 53.8 (SD 14.6). The disease severity groups were: mild (G1), moderate (G2) and severe/critical (G3). Anosmia was present in the acute disease phase in 45.2% of G1 patients, but only in 4.5% of G3 patients. Dyspnoea occurred frequently in more severe groups (40%, 51.8% and 63.7% for G1, G2 and G3 respectively), while cough and fatigue showed no relationship to disease severity. Females were more likely to experience persistent symptoms. PFT results were significantly decreased in more severe groups compared to the mild COVID-19 patients, diffusing capacity was 86.3%, 79% and 68% of predicted values in G1, G2 and G3 respectively. CONCLUSION: Anosmia during the acute phase was associated with mild disease, persisting dyspnoea was more frequent after more severe COVID-19. Females tended to have persisting symptoms in post-acute phase more frequently. PFT results showed decrease with disease severity.

590    __

$a

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a lidé $7 D006801

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a lidé středního věku $7 D008875

650    _2

$a mladiství $7 D000293

650    _2

$a mladý dospělý $7 D055815

650    _2

$a dospělí $7 D000328

650    _2

$a senioři $7 D000368

650    _2

$a senioři nad 80 let $7 D000369

650    12

$a COVID-19 $x komplikace $x diagnóza $7 D000086382

650    _2

$a SARS-CoV-2 $7 D000086402

650    _2

$a prospektivní studie $7 D011446

650    _2

$a anosmie $7 D000086582

650    _2

$a respirační funkční testy $7 D012129

650    _2

$a dyspnoe $x etiologie $7 D004417

655    _2

$a časopisecké články $7 D016428

700    1_

$a Jakubec, Petr, $u Department of Respiratory Diseases and Tuberculosis, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic $d 1971- $7 mzk2007381840

700    1_

$a Sova, Milan, $u Department of Respiratory Diseases and Tuberculosis, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic $u Department of Respiratory Diseases and Tuberculosis, University Hospital Brno and Faculty of Medicine and Dentistry, Masaryk University Brno, Czech Republic $d 1985- $7 xx0140833

700    1_

$a Mizera, Jan $u Department of Respiratory Diseases and Tuberculosis, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic $7 xx0238803

700    1_

$a Joppa, Pavol $u Department of Respiratory Diseases and Tuberculosis, University Hospital and Faculty of Medicine and Dentistry, Pavol Jozef Safarik University, Kosice, Slovak Republic $7 xx0106183

700    1_

$a Burget, Radim $u Department of Telecommunications, University of Technology, Brno, Czech Republic $7 jo2015889385

700    1_

$a Pobeha, Pavol $u Department of Respiratory Diseases and Tuberculosis, University Hospital and Faculty of Medicine and Dentistry, Pavol Jozef Safarik University, Kosice, Slovak Republic $7 xx0171817

773    0_

$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1804-7521 $g Roč. 167, č. 2 (2023), s. 185-191

856    41

$u https://pubmed.ncbi.nlm.nih.gov/36128850 $y Pubmed

910    __

$a ABA008 $b A 1502 $c 958 $y p $z 0

990    __

$a 20230707 $b ABA008

991    __

$a 20230802075158 $b ABA008

999    __

$a ok $b bmc $g 1964364 $s 1195209

BAS    __

$a 3

BAS    __

$a PreBMC-MEDLINE

BMC    __

$a 2023 $b 167 $c 2 $d 185-191 $e 20220906 $i 1804-7521 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606

LZP    __

$b NLK198 $a Pubmed-20230707